Sirtex Cover.proof 11 - School of Educators

More documents

Recommendations

Info

26 Section Board of Directors and Management Team
Board of Directors Dr Chris Roberts BE(Hons), MBA, PhD Non-Executive Chairman, Age 46 Dr Roberts graduated with honours in Chemical Engineering from the University of NSW, obtained an MBA from Macquarie University and completed a PhD at the University of NSW. He has over 24 years of experience in the medical device industry and is currently a Director and Executive Vice President of ResMed Inc, a medical device company listed on the NYSE and ASX. He previously held senior executive positions with Nucleus Ltd, BGS Medical Corporation, Electro-Biology Inc, Telectronics Pty Ltd and Domedica Pty Ltd. He has wide experience in commercialisation and marketing of new medical technology. Dr Bruce Gray MB BS, MS, PhD, FRACS Medical Director, Age 58 Dr Gray is a graduate of the University of Western Australia, University of Melbourne and Tufts University in Boston. He has held the position of Professor at the University of Western Australia for more than fourteen years and is the Medical Director of the Lions Cancer Institute Inc. and Cancer Research Institute Inc. He has extensive experience in medical research and is a world authority in the area of targeted anti-cancer techniques. He has published widely in the area of cancer treatment and particularly the treatment of liver cancer. He has served in various executive capacities on numerous academic and society boards. Dr Michael Panaccio BSc (Hons), MBA, PhD Non-Executive Director, Age 38 Dr Panaccio is a graduate of the University of Melbourne. On completion of his PhD, Dr Panaccio joined the Veterinary Research Institute to undertake commercially focussed research and development. During the period 1984-1995, Dr Panaccio developed strong collaborations with a number of multinational pharmaceutical companies and Rural Industry Funds. In 1996 Dr Panaccio joined Nomura/ JAFCO Investment (Asia) Limited, a Singapore based venture capital firm. Dr Panaccio is also a director of Technico Pty Limited, ExGenix Limited and Colloidal Dynamics Group Inc. Dr Colin Sutton BSc, PhD, FAICD Chief Executive Officer, Age 58 Dr Sutton trained in chemistry and biochemistry at the University of New South Wales. After serving in various technical and marketing positions in 1975 he joined Telectronics Limited, a leading manufacturer of cardiac pacemakers, as a marketing executive. He subsequently held a number of senior positions within Telectronics, including Chief Executive, North America; Chief Executive, Asia Pacific and Chief Executive, Europe. In 1994 Dr Sutton joined Air-Shields Inc., a leading manufacturer of neonatal equipment, responsible for sales in the Asia Pacific region. Following the acquisition by Hill- Rom Inc. of Air-Shields and Medaes in 1998, Dr Sutton was appointed General Manager – South Asia Pacific. Sirtex Medical Prospectus 2000 27
Page 1 and 2: S I R T E X M E D I C A L L I M I T
Page 3 and 4: Chairman’s Letter Chairman’s Le
Page 5 and 6: Section 2 1 The incidence of cancer
Page 7 and 8: Description of the Offer This Prosp
Page 9 and 10: • The extent of public and privat
Page 11 and 12: 4Section Industry Overview Sirtex M
Page 13 and 14: El-Serag and Mason (New England Jou
Page 15 and 16: 5Section Overview of Sirtex Medical
Page 17 and 18: Photograph of radioactive SIR-Spher
Page 19 and 20: Intellectual Property Position The
Page 21 and 22: Temp (c) 46 44 42 40 38 36 34 32 Th
Page 23 and 24: that has not been met with currentl
Page 25 and 26: 5.4.2 Costs of the Business The pro
Page 27: Manufacture of the SIR-Spheres will
Page 31 and 32: Section 7 Risk Factors 29
Page 33 and 34: Risk Factors Healthcare Funding Cha
Page 35 and 36: Section 8 Independent Accountants R
Page 37 and 38: Independent Accountants Report Duri
Page 39 and 40: Independent Accountants Report APPE
Page 41 and 42: Independent Accountants Report (e)
Page 43 and 44: Independent Accountants Report Cons
Page 45 and 46: Independent Accountants Report Cons
Page 47 and 48: Section 9 Reports on Patents 45
Page 49 and 50: Reports on Patents Patent Applicati
Page 51 and 52: Reports on Patents Date: 17 July 20
Page 53 and 54: Reports on Patents Patent Series 2
Page 55 and 56: Reports on Patents Trade Mark Serie
Page 57 and 58: Reports on Patents application unde
Page 59 and 60: Section 10Additional Information 57
Page 61 and 62: Additional Information attaching to
Page 63 and 64: Additional Information Restricted s
Page 65 and 66: Additional Information Material Con
Page 67 and 68: Additional Information • approval
Page 69 and 70: Additional Information Executive Se
Page 71 and 72: Additional Information Consents and
Page 73 and 74: Additional Information of a directo
Page 75 and 76: Glossary of Terms and References Th
Page 77 and 78: Glossary of Terms and References Bu
Page 79 and 80:
A B C E F Application Form SIRTEX M
Page 81 and 82:
A B C E F Application Form SIRTEX M
Page 83 and 84:
Design and Production: Downer Manci
show all

Sirtex Cover.proof 11 - School of Educators

Create successful ePaper yourself

Delete template?

Save as template?